Delcath Systems (DCTH) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/22/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
- Emirates refusing to take delivery of first 10 Boeing 777X jets
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- Crude Inventory Rose 2 Million Barrels Last Week - EIA
- Wall St ends higher on chip stocks recovery; earnings in focus
- Palo Alto Networks to acquire Embrace to expand observability tools
Canaccord Genuity Reiterates Buy Rating on Delcath Systems (DCTH)
March 27, 2024 8:09 AM EDTCanaccord Genuity analyst Bill Maughan reiterated a Buy rating and $21.00 price target on Delcath Systems (NASDAQ: DCTH).
The analyst commented, "Delcath reported 4Q23 results this morning and gave an update on the early launch of Hepzato, which came available in January for the treatment of metastatic uveal melanoma... More
